HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.

AbstractBACKGROUND:
The ability of chronic valproate (VPA) to reduce arachidonic acid (AA) turnover in brain phospholipids of unanesthetized rats has been ascribed to its inhibition of acyl-CoA synthetase (Acsl)-mediated activation of AA to AA-CoA. Our aim was to identify a rat Acsl isoenzyme that could be inhibited by VPA in vitro.
METHODS:
Rat Acsl3-, Acsl6v1- and Acsl6v2-, and Acsl4-flag proteins were expressed in E. coli, and the ability of VPA to inhibit their activation of long-chain fatty acids to acyl-CoA was estimated using Michaelis-Menten kinetics.
RESULTS:
VPA uncompetitively inhibited Acsl4-mediated conversion of AA and of docosahexaenoic (DHA) but not of palmitic acid to acyl-CoA, but did not affect AA conversion by Acsl3, Acsl6v1 or Acsl6v2. Acsl4-mediated conversion of AA to AA-CoA showed substrate inhibition and had a 10-times higher catalytic efficiency than did conversion of DHA to DHA-CoA. Butyrate, octanoate, or lithium did not inhibit AA activation by Acsl4.
CONCLUSIONS:
VPA's ability to inhibit Acsl4 activation of AA and of DHA to their respective acyl-CoAs, when related to the higher catalytic efficiency of AA than DHA conversion, may account for VPA's selective reduction of AA turnover in rat brain phospholipids, and contribute to VPA's efficacy against bipolar disorder.
AuthorsJakob A Shimshoni, Mireille Basselin, Lei O Li, Rosalind A Coleman, Stanley I Rapoport, Hiren R Modi
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1811 Issue 3 Pg. 163-9 (Mar 2011) ISSN: 0006-3002 [Print] Netherlands
PMID21184843 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Anticonvulsants
  • Arachidonic Acids
  • Isoenzymes
  • Nerve Tissue Proteins
  • Recombinant Proteins
  • Docosahexaenoic Acids
  • Arachidonic Acid
  • Valproic Acid
  • Acsl4 protein, rat
  • Coenzyme A Ligases
Topics
  • Acylation (drug effects)
  • Animals
  • Anticonvulsants (chemistry, pharmacology)
  • Arachidonic Acid (chemistry, metabolism)
  • Arachidonic Acids (chemistry, metabolism)
  • Bipolar Disorder (drug therapy, enzymology)
  • Brain (enzymology)
  • Coenzyme A Ligases (chemistry, genetics, metabolism)
  • Docosahexaenoic Acids (chemistry, metabolism)
  • Enzyme Activation (drug effects)
  • Escherichia coli
  • Humans
  • Isoenzymes (chemistry, metabolism)
  • Nerve Tissue Proteins (chemistry, metabolism)
  • Rats
  • Recombinant Proteins (chemistry, metabolism)
  • Valproic Acid (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: